These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 13427779)

  • 1. [Further consideration of the evaluation of coronary dilator drugs].
    SETNIKAR I
    Farmaco Sci; 1957; 12(3):218-9. PubMed ID: 13427779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical effect of a new synthetic coronary dilator drug; 7-alpha-(acetoxyethyl)-oxyflavone].
    STARCICH R
    Minerva Med; 1956 Sep; 47(78):887-97. PubMed ID: 13387209
    [No Abstract]   [Full Text] [Related]  

  • 3. The combined effects of reserpine and various coronary dilator drugs. An experimental study.
    MELVILLE KI; VARMA DR
    Can Med Assoc J; 1962 Jun; 86(22):1014-9. PubMed ID: 14472481
    [No Abstract]   [Full Text] [Related]  

  • 4. Coronary vasodilating drugs.
    WILLIS PW; DUFF IF
    Med Clin North Am; 1957 Mar; 41(2):449-69. PubMed ID: 13407229
    [No Abstract]   [Full Text] [Related]  

  • 5. [Observations on the evaluation of coronary dilator drugs].
    SETNIKAR I
    Farmaco Sci; 1956; 11(9):750-76. PubMed ID: 13414848
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of coronary dilator drugs].
    SETNIKAR I
    Farmaco Sci; 1956; 11(12):1018-21. PubMed ID: 13414868
    [No Abstract]   [Full Text] [Related]  

  • 7. Regional differences in response of terminal vascular bed to vasoactive agents.
    ZWEIFACH BW; METZ DB
    Am J Physiol; 1955 Jul; 182(1):155-65. PubMed ID: 13248960
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of peripheral vasodilator and vasoconstrictor drugs on the intraocular (choroidal) blood volume.
    BETTMAN JW; FELLOWS V
    Trans Am Acad Ophthalmol Otolaryngol; 1962; 66():480-7. PubMed ID: 13868666
    [No Abstract]   [Full Text] [Related]  

  • 9. [Angiographic study of changes induced by some coronary dilator drugs].
    SPARACIA A; BAZAN M
    Minerva Cardioangiol; 1962 Mar; 10():190-6. PubMed ID: 13915563
    [No Abstract]   [Full Text] [Related]  

  • 10. Choice of a coronary vasodilator drug in clinical practice; evaluation of effects by electrocardiographic tests.
    RUSSEK HI; URBACH KF; DOERNER AA; ZOHMAN BL
    J Am Med Assoc; 1953 Sep; 153(3):207-11. PubMed ID: 13069293
    [No Abstract]   [Full Text] [Related]  

  • 11. The comparative sensitivity of isolated coronary and systemic vessels to vasomotor agents.
    OPPELT WW; EDERSTROM HE
    Angiology; 1959 Jun; 10(3):153-7. PubMed ID: 13661628
    [No Abstract]   [Full Text] [Related]  

  • 12. [Vaso-dilator drugs].
    WAREMBOURG H; DESRUELLES J
    Fr Med; 1954 Jun; 17(6):5-8. PubMed ID: 13173763
    [No Abstract]   [Full Text] [Related]  

  • 13. An evaluation of certain vasodilator drugs by a heat flow technic.
    CATCHPOLE BN; JEPSON RP
    Circulation; 1954 Mar; 9(3):408-15. PubMed ID: 13141370
    [No Abstract]   [Full Text] [Related]  

  • 14. [Coronary vasodilators].
    LITTER M
    Sem Med; 1956 May; 108(24):775-810. PubMed ID: 13351798
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents?
    Cleland JG
    Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314
    [No Abstract]   [Full Text] [Related]  

  • 16. Central vasomotor actions of some analeptic drugs.
    WERNER G
    Arch Int Pharmacodyn Ther; 1957 Nov; 112(3-4):437-50. PubMed ID: 13498869
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacological properties of some new coronary dilators, particularly of flavone-7-ethyl-oxyacetate].
    SETNIKAR I; ZANOLINI T
    Farmaco Sci; 1956; 11(10):855-82. PubMed ID: 13414855
    [No Abstract]   [Full Text] [Related]  

  • 18. [The activity of human coronary arteries in vitro].
    Godfraind T
    Bull Acad Natl Med; 1985 Feb; 169(2):273-80. PubMed ID: 3899298
    [No Abstract]   [Full Text] [Related]  

  • 19. [Peripheral vasomotor drugs].
    BRUCKE F
    Wien Med Wochenschr; 1956 Nov; 106(45):931-2. PubMed ID: 13401751
    [No Abstract]   [Full Text] [Related]  

  • 20. [The treatment of cardiovascular diseases with carnigen].
    SCHEMBRA FW
    Med Klin; 1955 May; 50(19):827-9. PubMed ID: 14383220
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.